Table 3.

Planned tables and figures

Proposed tables and figures	Table/figure	Description
For the manuscript	Table 1 Table 2 Figure 1 Figure 2	Baseline patient characteristics (by treatment group) Primary and secondary outcomes (by treatment group) Flow of participants through the trial (see Figure 1) Population-averaged mean blood glucose (by treatment)
For the online Appendix	Table S1	Description of consent process
	Table S2	Process of care measured in ICU (blood glucose measurement technique, insulin nutrition, corticosteroids and catecholamines administered)
	Table S3	Subgroup analysis (primary and secondary outcomes for HbA1c ≥ 53 mmol/mol
	Table S4	Summary of protocol deviations/adverse events
	Figure S1	Insulin administration v time (units per day)
	Figure S2	Population-averaged mean blood glucose (by treatment) for subgroup HbA1c ≥ 53 mmol/mol
	Figure S3	Cumulative incident plots for the subhazards (ICU or hospital discharge), with death as a competing risk

HbA_1c = glycated haemoglobin; ICU = intensive care unit.